x min read

Stocks news: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cabot Oil & Gas Corporation (NYSE:COG), Bristol-Myers Squibb Company (NYSE:BMY)

Stocks news: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cabot Oil & Gas Corporation (NYSE:COG), Bristol-Myers Squibb Company (NYSE:BMY)
Written by
Ryan Mitchell
Published on
October 27, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) reported that the adoption of final opinion for Iclusig by Committee for Medicinal Products for Human Use in Europe. The EMA suggested that Iclusig continue to be used in accordance with its already approved indications as a treatment of certain leukaemias and confirmed that the benefit-risk profile of Iclusig continues to be positive in each of these indications (ARIA). Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) stock hit highest price at $5.86, beginning with a price of $5.74 and reported an increase of 2.10% to the closed at $5.83 with a day range of $5.54-$5.86. The total market capitalization remained 1.090 Billion, total volume of 5.5 Million shares held in the session was surprisingly higher than its average volume of 7143.30 shares.Cabot Oil & Gas Corporation (NYSE:COG) released that its third quarter earnings of $0.20 a share, excluding non-recurring items, $0.02 lower than the Capital IQ Consensus anticipates of $0.22. The firm now has around 194 Mmcf per day of natural gas volumes hedged for 2015 at a weighted average floor of $3.99 per Mcf. Cabot Oil & Gas Corporation (NYSE:COG) stock has highest price of $32.789 in last session, beginning with a price of $32.02 and reported a lose of -0.67% to the closed at $31.23 with a day range of $30.05-$32.789. The stock is going forward its 52-week low with 12.54% and moving down from its 52 week high price with -25.16%.Bristol-Myers Squibb Company (NYSE:BMY) released that its third quarter earnings of $0.45 per share, excluding non-recurring items, $0.03 improved than the Capital IQ Consensus anticipates of $0.42. Excluding the divested Diabetes Alliance, worldwide revenues surged 7 percent. U.S. revenues dropped 3% to $2B in the quarter compared to the similar period a year ago. Shares of Bristol-Myers Squibb Company (NYSE:BMY) traded at $53.63 by surging 2.15% with price volatility of 2.07% for a week and 2.18% for a month. Its beta stands at 0.40 times.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.